Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and 11C-methionine-, 11C-choline-, and 18F-fluorodeoxyglucose-PET

Gutrecht JA, Berger JR, RH Jones Jr, Mancall AC (2002) Monofocal acute inflammatory demyelination (MAID): a unique disorder simulating brain neoplasm. South Med J 95:1180–1186

Tan HM, Chan LL, Chuah KL, Goh NS, Tang KK (2004) Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis. Br J Radiol 77:153–156

Masdeu JC, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P (2000) Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 54:1427–1433

Bitsch A, Bruhn H, Vougioukas V, Stringaris A, Lassmann H, Frahm J, Bruck W (1999) Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 20:1619–1627

Saindane AM, Cha S, Law M, Xue X, Zagzag EAKD (2002) Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 23:1378–1386

Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE (1994) Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 31:365–373

Kapouleas I, Alavi A, Alves WM, Gur RE, Weiss DW (1991) Registration of three-dimensional MR and PET images of the human brain without markers. Radiology 181:731–739

Heyman D, Delhaye M, Fournier D, Mercier P, Rousselet MC, Menei P (2001) Pseudotumoral demyelination: a diagnosis pitfall (report of three cases). J Neuro-Oncol 54:71–76

Akimoto J, Nakajima N, Saida A, Haraoka J, Kudo M (2006) Monofocal acute inflammatory demyelination manifesting as open ring sign. Case report. Neurol Med Chir (Tokyo) 46:353–357

Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, McDonald WI (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117:49–58

Silva HC, Callegaro D, Marchiori PE, Scaff M, Tsanaclis AM (1999) Magnetic resonance imaging in five patients with a tumefactive demyelinating lesion in the central nervous system. Arq Neuropsiquiatr 57:921–926

Tovi M, Hartman M, Lilja A, Ericsson A (1994) MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens. Acta Radiol 35:495–505

Brenner RE, Munro PM, Williams SC, Bell JD, Barker GJ, Hawkins CP, Landon DN, McDonald WI (1993) The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 29:737–745

Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M (1991) Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 180:467–474

Padma MV, Adineh M, Pugar K, Mukherjee J, Satter M, Shi B, Dunigan K, Bidwell K, Ezzeddine B, Mantil J (2005) Functional imaging of a large demyelinating lesion. J Clin Neurosci 12:176–178

Schiepers C, Van Hecke P, Vandenberghe R, Van Oostende S, Dupont P, Demaerel P, Bormans G, Carton H (1997) Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis. Mult Scler 3:8–17

Bakshi R, Miletich RS, Kinkel PR, Emmet ML, Kinkel WR (1998) High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging 8:228–234

Miwa K, Shinoda J, Yano H, Okumura A, Iwama T, Nakashima T, Sakai N (2004) Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study. J Neurol Neurosurg Psychiatry 75:1457–1462

Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T (2008) Metabolic assessment of gliomas using 11C-methionine, [18F]fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29:1176–1182

Dethy S, Goldman S, Blecic S, Luxen A, Levivier M, Hildebrand J (1994) Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. J Nucl Med 35:1162–1166

Dethy S, Manto M, Kentos A, Konopnicki D, Pirotte B, Goldman S, Hildebrand J (1995) PET findings in a brain abscess associated with a silent atrial septal defect. Clin Neurol Neurosurg 97:349–353

Jacobs A (1995) Amino acid uptake in ischemically compromised brain tissue. Stroke 26:1859–1866

Singhal T, Narayanan TK, Jain V, Mukherjee J, Mantil J (2008) 11C-l-Methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 10:1–18

Huang Z, Zuo C, Guan Y, Zhang Z, Liu P, Xue F, Lin X (2008) Misdiagnoses of 11C-choline combined with 18F-FDG PET imaging in brain tumours. Nucl Med Commun 29:354–358

Hara T (2002) 11C-Choline and 2-deoxy-2-[18F]fluoro-d-glucose in tumor imaging with positron emission tomography. Mol Imaging Biol 4:267–273

Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, Utriainen T, Roivainen A, Kalimo H, Minn H (2003) Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neuro-Oncol 62:329–338